Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-21-057077
Filing Date
2021-11-15
Accepted
2021-11-15 17:24:56
Documents
121
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-K/A qtnt-10ka_20210331.htm   iXBRL 10-K/A 14055055
2 EX-23.1 qtnt-ex231_11.htm EX-23.1 35671
3 EX-31.1 qtnt-ex311_10.htm EX-31.1 16147
4 EX-31.2 qtnt-ex312_17.htm EX-31.2 16011
5 EX-32.1 qtnt-ex321_8.htm EX-32.1 4911
6 EX-32.2 qtnt-ex322_18.htm EX-32.2 4818
  Complete submission text file 0001564590-21-057077.txt   83299642

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20210331.xsd EX-101.SCH 96589
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qtnt-20210331_cal.xml EX-101.CAL 116606
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qtnt-20210331_def.xml EX-101.DEF 435439
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20210331_lab.xml EX-101.LAB 693875
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20210331_pre.xml EX-101.PRE 748975
12 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-10ka_20210331_htm.xml XML 23082672
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

EIN.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-36415 | Film No.: 211412614
SIC: 2835 In Vitro & In Vivo Diagnostic Substances